SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 1 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $34,000 | -27.7% | 161,373 | -1.1% | 0.00% | – |
| Q1 2022 | $47,000 | +104.3% | 163,172 | +94.1% | 0.00% | – |
| Q4 2021 | $23,000 | -76.5% | 84,075 | -60.5% | 0.00% | – |
| Q3 2021 | $98,000 | +653.8% | 213,075 | +878.5% | 0.00% | – |
| Q2 2021 | $13,000 | +116.7% | 21,775 | +101.1% | 0.00% | – |
| Q4 2018 | $6,000 | – | 10,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 684,926 | $465,000 | 0.22% |
| Alyeska Investment Group, L.P. | 5,000,000 | $3,395,000 | 0.04% |
| Third Security, LLC | 378,239 | $256,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,000 | $41,000 | 0.00% |
| SCOPUS ASSET MANAGEMENT, L.P. | 225,000 | $153,000 | 0.00% |
| Virtu Financial LLC | 94,070 | $64,000 | 0.00% |
| 683 Capital Management, LLC | 42,858 | $29,000 | 0.00% |
| FNY Investment Advisers, LLC | 7,000 | $4,000 | 0.00% |
| UBS Group AG | 3,978 | $2,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |